Clinical significance of serum carbohydrate antigen 19.9 and duke pancreatic monoclonal antigen type 2 for the prediction of hematogenous metastases in patients with pancreatic ducal adenocarcinoma

医学 转移 CA19-9号 腺癌 胃肠病学 单克隆抗体 抗原 内科学 胰腺癌 癌症 抗体 免疫学
作者
Hiroshi Kurahara,Kosei Maemura,Yuko Mataki,Masahiko Sakoda,Satoshi Iino,Takaaki Arigami,Shinichiro Mori,Shinichi Ueno,Hiroyuki Shinchi,Sonshin Takao,Shoji Natsugoe
出处
期刊:Pancreatology [Elsevier BV]
卷期号:16 (6): 1051-1056 被引量:5
标识
DOI:10.1016/j.pan.2016.09.014
摘要

The aim of the present study was to investigate the effectiveness of serum carbohydrate antigen (CA) 19.9 and duke pancreatic monoclonal antigen type 2 (DUPAN-2) levels in the prediction of early hematogenous metastases and as indicators of neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC).Of the 293 enrolled PDAC patients, 61 had hematogenous metastases at the initial evaluation. One hundred and twenty patients without metastases underwent surgical resection. Of the 120 patients who underwent surgical resection, 45 underwent preoperative treatment and 29 developed early hematogenous metastases within 1 year after the surgery. In patients who underwent preoperative therapy, serum CA 19.9 and DUPAN-2 levels were measured within 2 weeks before the preoperative therapy and the subsequent surgery.The elevated serum CA 19.9 and DUPAN-2 levels were significantly associated with hematogenous metastasis at initial evaluation and early hematogenous metastasis after surgery. The rate of early hematogenous metastasis and overall survival (OS) in patients with high CA 19.9 and/or high DUPAN-2 (CA 19.9 > 200 U/mL and/or DUPAN-2 >300 U/mL) were 46.3% and 18 months, respectively, whereas the metastatic rate and OS in patients with low CA 19.9 and DUPAN-2 were 12.7% and 37.5 months, respectively. Furthermore, in patients with high CA 19.9 and/or high DUPAN-2, preoperative therapy significantly reduced the rate of early hematogenous metastasis and prolonged the OS.Serum CA 19.9 and DUPAN-2 levels are useful predictors of early hematogenous metastasis and indicators for effectiveness of neoadjuvant therapy in PDAC patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yoyo发布了新的文献求助10
刚刚
思源应助Wl采纳,获得10
2秒前
共享精神应助橘笙采纳,获得10
3秒前
耍酷问兰发布了新的文献求助10
4秒前
科研通AI2S应助nczpf2010采纳,获得10
6秒前
搜集达人应助杜兰特工队采纳,获得10
11秒前
热心市民小红花应助牛马采纳,获得10
13秒前
热心市民小红花应助牛马采纳,获得10
13秒前
13秒前
Ava应助WJM采纳,获得10
17秒前
科研通AI2S应助nczpf2010采纳,获得10
18秒前
酷酷飞烟发布了新的文献求助10
18秒前
Bressanone发布了新的文献求助10
20秒前
李健的小迷弟应助老吴采纳,获得10
20秒前
大气的雅山完成签到,获得积分10
22秒前
shaoshao86完成签到,获得积分10
28秒前
28秒前
华仔应助科研通管家采纳,获得10
28秒前
逆时针应助科研通管家采纳,获得10
28秒前
MchemG应助科研通管家采纳,获得10
28秒前
研友_VZG7GZ应助科研通管家采纳,获得10
28秒前
wang应助科研通管家采纳,获得10
28秒前
wang应助科研通管家采纳,获得10
28秒前
ding应助科研通管家采纳,获得10
28秒前
上官若男应助科研通管家采纳,获得10
29秒前
思源应助科研通管家采纳,获得10
29秒前
田様应助科研通管家采纳,获得10
29秒前
小北发布了新的文献求助10
29秒前
NexusExplorer应助Quinna采纳,获得10
31秒前
32秒前
32秒前
量子星尘发布了新的文献求助10
34秒前
WJM发布了新的文献求助10
38秒前
老吴发布了新的文献求助10
39秒前
40秒前
佳语妍说完成签到,获得积分10
41秒前
42秒前
43秒前
酷波er应助平淡的凝竹采纳,获得10
44秒前
46秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989069
求助须知:如何正确求助?哪些是违规求助? 3531351
关于积分的说明 11253589
捐赠科研通 3269939
什么是DOI,文献DOI怎么找? 1804851
邀请新用户注册赠送积分活动 882074
科研通“疑难数据库(出版商)”最低求助积分说明 809073